Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorInonu University
About this trial
This randomized controlled study will compare the effects of the ShotBlocker device and the Helfer Skin Tap Technique on pain and fear during intramuscular hormone injections in premenopausal and postmenopausal breast cancer patients. Ninety-nine participants will be randomly assigned to three groups (ShotBlocker, Helfer, control). All injections will be administered by the same nurse using standardized procedures. Pain will be assessed with the Visual Analog Scale, and fear with the Injection Fear Scale. The study aims to identify effective nonpharmacological methods to enhance patient comfort, support treatment adherence, and improve nursing care quality.
Eligibility criteria
Qualifiers
Patients aged between 18 and 65 years.
Patients diagnosed with breast cancer.
Requirement of intramuscular (IM) injection of premenopausal or postmenopausal hormonal medications as part of their prescribed treatment.
Cognitive competence to provide informed consent for the injection procedure. Intact skin integrity and normal sensory perception at the injection site (gluteal region).
Disqualifiers
History of chronic pain disorders, neuropathic pain syndrome, or any disease requiring regular analgesic use.
Presence of neurological or cognitive disorders that may alter pain or fear perception.
Use of analgesics within the last 24 hours (or a specific timeframe relevant to your study).
Trial design
Treatments tested in this trial
- ShotBlocker device
- This involves rhythmic, gentle tapping with the fingertips on the skin surrounding the gluteal injection site.
Treatment groups
99 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov